- New China Life’s value of new business in the first half of the year is 3.90 billion yuan.
- Earnings per share (EPS) is 3.55 yuan.
- The International Financial Reporting Standards (IFRS) net income is 11.08 billion yuan.
- IFRS total revenue amounts to 55.31 billion yuan.
- Analyst recommendations include 14 buy ratings, 8 hold ratings, and 1 sell rating.
A look at New China Life Insurance Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, New China Life Insurance Company Limited appears to have a positive long-term outlook. With high scores in Dividend, Growth, and Momentum, the company seems to be performing well in terms of providing returns to investors, showing strong potential for future expansion, and maintaining a positive market momentum.
However, the lower score in Resilience may indicate some potential vulnerability to external factors or market fluctuations. Despite this, the overall high scores in other areas suggest that New China Life Insurance remains a promising investment opportunity in the insurance sector, offering a range of insurance products and services both locally and internationally.
### Summary: New China Life Insurance Company Limited specializes in providing various life insurance products and services, operating as an insurance agent and offering insurance consulting. Its key offerings include life insurance, accident insurance, and health insurance in multiple currencies. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
